Apr 13, 2011 ... All randomised controlled clinical trials which focus on the use of naltrexone maintenance treatment versus placebo, or other treatments to ...

  onlinelibrary.wiley.com

Naltrexone, sold under the brand names ReVia and Vivitrol among others, is a medication primarily used to manage alcohol or opioid dependence.

  en.wikipedia.org

... is a beautiful merger of form and function: designed to meet the stringent demands gamers' have in a headset, without looking out of place for everyday use.

  www.ttesports.ru

  www.opiates.com

Naltrexone was more effective than placebo for relapse prevention in opioid ... Drug Therapy, Combination; Female; Guanfacine/therapeutic use*; Humans ...

  www.ncbi.nlm.nih.gov

  healthjade.com

Request PDF on ResearchGate | On Jun 1, 2010, H. M. Pettinati and others published EFFICACY OF EXTENDED-RELEASE NALTREXONE BASED ON THE ...

  www.researchgate.net

  www.webmd.com

[An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients].

  www.ncbi.nlm.nih.gov

  www.addictionsearch.com

  www.drugs.com

Download Citation on ResearchGate | The efficiency of the medical rehabilitation program with the use of injectable naltrexone for alcohol addicted patients who ...

  www.researchgate.net

  www.tabletwise.com

28 июн 2018 ... The first group received implantation of 1000 mg naltrexone every 2 months during ..... Creation and use of new algorithms for medical research ...

  www.researchgate.net

Действующее вещество ›› Налтрексон* (Naltrexone*) Латинское название Naltrexone FV АТХ: ›› V03AB30 Налтрексон Фармакологические группы: ...

  dic.academic.ru

  pillintrip.com

Налтрексон (Naltrexone): лекарственное вещество - антагонист наркотиков; применяется для поддерживающего ... Смотреть что такое "Налтрексон ( Naltrexone)" в других словарях: ... Continuing to use this site, you agree with this .

  dic.academic.ru

An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients.

  www.researchgate.net

Page generated - 0.0145769119 (57d3d1b73724657fab2316c35ec7a064)